Form4insider filings, from the source

SEC Form 4 · accession 0001104659-19-002327

SUPERNUS PHARMACEUTICALS, INC. · SUPN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jack A. Khattar
Officer — President, CEO · Director
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 6:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jan 15, 2019G400$0.00D453,865D
Common StockJan 15, 2019G400$0.00D453,465D
Common StockJan 15, 2019G400$0.00D453,065D
Common StockJan 15, 2019G400$0.00A2,900IBy son
Common Stockholding———1,085,950IBy the KBT Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses